ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 731129 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 731129; 2) Community: the network communities that were significantly associated with the response to NSC 731129; 3) Molecule: the relationships between components within communities and NSC 731129; 4) MDR: the compounds that were significantly associated with the NSC 731129.

NSC Compound Enrichment Correlation
NSC 761676 Null 0.0285477013888565 0.2300308
NSC 80103 2,3-Butanediol, 1,4-bis(2-methyl-1-aziridinyl)- (8CI) 0.0285477013888565 0.059844211
NSC 134228 .alpha.-Toluenethiol, .alpha.-(nitromethyl)-,acetate (ester) (8CI) 0.0285477013888569 0.27602288
NSC 287459 Cytarabine AY 0.0285477013888569 0.017224398
NSC 673824 Null 0.0285477013888569 0.15625899
NSC 686557 Null 0.0285477013888569 0.17171721
NSC 697192 Decanediamide, N,N'-bis[2-(2-hydroxy-1-naphthalenyl)- 5-(3,4-dihydroxyphenyl)methylene]-4-oxo- 3-thiazolidinyl]- 0.0285477013888569 0.0087885171
NSC 705534 Faradiol 0.0285477013888569 -0.072109609
NSC 720290 Methyl-7.alpha.,12.alpha.-Diacetoxy-5.beta.-cholan-24-oate-3 -spiro-6'-(1',2',4',5'-tetraoxacyclohexane)-3'-spirocyclohexane 0.0285477013888569 0.12316664
NSC 727350 benzoanthracenone 0.0285477013888569 0.0025568281
Total:51  Current:29    [First] [Prev] [Next] [Last]